Global High-Throughput Screening (HTS) for Drug Discovery Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Consumables
  • 1.3.3 Instruments
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Pharmaceuticals
  • 1.4.3 Biological Laboratories
  • 1.4.4 Others
• 1.5 Global High-Throughput Screening (HTS) for Drug Discovery Market Size & Forecast
  • 1.5.1 Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global High-Throughput Screening (HTS) for Drug Discovery Sales Quantity (2021-2032)
  • 1.5.3 Global High-Throughput Screening (HTS) for Drug Discovery Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Thermo Fisher Scientific
  • 2.1.1 Thermo Fisher Scientific Details
  • 2.1.2 Thermo Fisher Scientific Major Business
  • 2.1.3 Thermo Fisher Scientific High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.1.4 Thermo Fisher Scientific High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
• 2.2 Agilent
  • 2.2.1 Agilent Details
  • 2.2.2 Agilent Major Business
  • 2.2.3 Agilent High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.2.4 Agilent High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Agilent Recent Developments/Updates
• 2.3 Merck
  • 2.3.1 Merck Details
  • 2.3.2 Merck Major Business
  • 2.3.3 Merck High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.3.4 Merck High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Merck Recent Developments/Updates
• 2.4 Danaher
  • 2.4.1 Danaher Details
  • 2.4.2 Danaher Major Business
  • 2.4.3 Danaher High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.4.4 Danaher High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Danaher Recent Developments/Updates
• 2.5 Revvity
  • 2.5.1 Revvity Details
  • 2.5.2 Revvity Major Business
  • 2.5.3 Revvity High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.5.4 Revvity High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Revvity Recent Developments/Updates
• 2.6 Tecan Group
  • 2.6.1 Tecan Group Details
  • 2.6.2 Tecan Group Major Business
  • 2.6.3 Tecan Group High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.6.4 Tecan Group High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Tecan Group Recent Developments/Updates
• 2.7 Bio-Rad Laboratories
  • 2.7.1 Bio-Rad Laboratories Details
  • 2.7.2 Bio-Rad Laboratories Major Business
  • 2.7.3 Bio-Rad Laboratories High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.7.4 Bio-Rad Laboratories High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Bio-Rad Laboratories Recent Developments/Updates
• 2.8 Corning Incorporated
  • 2.8.1 Corning Incorporated Details
  • 2.8.2 Corning Incorporated Major Business
  • 2.8.3 Corning Incorporated High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.8.4 Corning Incorporated High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Corning Incorporated Recent Developments/Updates
• 2.9 Mettler-Toledo International
  • 2.9.1 Mettler-Toledo International Details
  • 2.9.2 Mettler-Toledo International Major Business
  • 2.9.3 Mettler-Toledo International High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.9.4 Mettler-Toledo International High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Mettler-Toledo International Recent Developments/Updates
• 2.10 Lonza
  • 2.10.1 Lonza Details
  • 2.10.2 Lonza Major Business
  • 2.10.3 Lonza High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.10.4 Lonza High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Lonza Recent Developments/Updates
• 2.11 Waters Corporation
  • 2.11.1 Waters Corporation Details
  • 2.11.2 Waters Corporation Major Business
  • 2.11.3 Waters Corporation High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.11.4 Waters Corporation High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Waters Corporation Recent Developments/Updates
• 2.12 Sartorius AG
  • 2.12.1 Sartorius AG Details
  • 2.12.2 Sartorius AG Major Business
  • 2.12.3 Sartorius AG High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.12.4 Sartorius AG High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Sartorius AG Recent Developments/Updates
• 2.13 Eppendorf
  • 2.13.1 Eppendorf Details
  • 2.13.2 Eppendorf Major Business
  • 2.13.3 Eppendorf High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.13.4 Eppendorf High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Eppendorf Recent Developments/Updates
• 2.14 Porvair
  • 2.14.1 Porvair Details
  • 2.14.2 Porvair Major Business
  • 2.14.3 Porvair High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.14.4 Porvair High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 Porvair Recent Developments/Updates
• 2.15 Greiner AG
  • 2.15.1 Greiner AG Details
  • 2.15.2 Greiner AG Major Business
  • 2.15.3 Greiner AG High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.15.4 Greiner AG High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Greiner AG Recent Developments/Updates
• 2.16 Charles River Laboratories
  • 2.16.1 Charles River Laboratories Details
  • 2.16.2 Charles River Laboratories Major Business
  • 2.16.3 Charles River Laboratories High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.16.4 Charles River Laboratories High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 Charles River Laboratories Recent Developments/Updates
• 2.17 Eurofins Scientific
  • 2.17.1 Eurofins Scientific Details
  • 2.17.2 Eurofins Scientific Major Business
  • 2.17.3 Eurofins Scientific High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.17.4 Eurofins Scientific High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 Eurofins Scientific Recent Developments/Updates
• 2.18 Hamilton
  • 2.18.1 Hamilton Details
  • 2.18.2 Hamilton Major Business
  • 2.18.3 Hamilton High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.18.4 Hamilton High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 Hamilton Recent Developments/Updates
• 2.19 Aurora Biomed
  • 2.19.1 Aurora Biomed Details
  • 2.19.2 Aurora Biomed Major Business
  • 2.19.3 Aurora Biomed High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.19.4 Aurora Biomed High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.19.5 Aurora Biomed Recent Developments/Updates
• 2.20 Gilson
  • 2.20.1 Gilson Details
  • 2.20.2 Gilson Major Business
  • 2.20.3 Gilson High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.20.4 Gilson High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.20.5 Gilson Recent Developments/Updates
• 2.21 Brand GmbH+Co
  • 2.21.1 Brand GmbH+Co Details
  • 2.21.2 Brand GmbH+Co Major Business
  • 2.21.3 Brand GmbH+Co High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.21.4 Brand GmbH+Co High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.21.5 Brand GmbH+Co Recent Developments/Updates
• 2.22 BMG Labtech
  • 2.22.1 BMG Labtech Details
  • 2.22.2 BMG Labtech Major Business
  • 2.22.3 BMG Labtech High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.22.4 BMG Labtech High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.22.5 BMG Labtech Recent Developments/Updates
• 2.23 DIANA Biotechnologies
  • 2.23.1 DIANA Biotechnologies Details
  • 2.23.2 DIANA Biotechnologies Major Business
  • 2.23.3 DIANA Biotechnologies High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.23.4 DIANA Biotechnologies High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.23.5 DIANA Biotechnologies Recent Developments/Updates
• 2.24 Creative Biolabs
  • 2.24.1 Creative Biolabs Details
  • 2.24.2 Creative Biolabs Major Business
  • 2.24.3 Creative Biolabs High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.24.4 Creative Biolabs High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.24.5 Creative Biolabs Recent Developments/Updates
• 2.25 HighRes Biosolutions
  • 2.25.1 HighRes Biosolutions Details
  • 2.25.2 HighRes Biosolutions Major Business
  • 2.25.3 HighRes Biosolutions High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.25.4 HighRes Biosolutions High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.25.5 HighRes Biosolutions Recent Developments/Updates
• 2.26 Biomat
  • 2.26.1 Biomat Details
  • 2.26.2 Biomat Major Business
  • 2.26.3 Biomat High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.26.4 Biomat High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.26.5 Biomat Recent Developments/Updates
• 2.27 AXXAM S.p.A.
  • 2.27.1 AXXAM S.p.A. Details
  • 2.27.2 AXXAM S.p.A. Major Business
  • 2.27.3 AXXAM S.p.A. High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.27.4 AXXAM S.p.A. High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.27.5 AXXAM S.p.A. Recent Developments/Updates
• 2.28 Sygnature Discovery
  • 2.28.1 Sygnature Discovery Details
  • 2.28.2 Sygnature Discovery Major Business
  • 2.28.3 Sygnature Discovery High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.28.4 Sygnature Discovery High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.28.5 Sygnature Discovery Recent Developments/Updates
• 2.29 Crown Bioscience
  • 2.29.1 Crown Bioscience Details
  • 2.29.2 Crown Bioscience Major Business
  • 2.29.3 Crown Bioscience High-Throughput Screening (HTS) for Drug Discovery Product and Services
  • 2.29.4 Crown Bioscience High-Throughput Screening (HTS) for Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.29.5 Crown Bioscience Recent Developments/Updates

3 Competitive Environment: High-Throughput Screening (HTS) for Drug Discovery by Manufacturer

• 3.1 Global High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global High-Throughput Screening (HTS) for Drug Discovery Revenue by Manufacturer (2021-2026)
• 3.3 Global High-Throughput Screening (HTS) for Drug Discovery Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of High-Throughput Screening (HTS) for Drug Discovery by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 High-Throughput Screening (HTS) for Drug Discovery Manufacturer Market Share in 2025
  • 3.4.3 Top 6 High-Throughput Screening (HTS) for Drug Discovery Manufacturer Market Share in 2025
• 3.5 High-Throughput Screening (HTS) for Drug Discovery Market: Overall Company Footprint Analysis
  • 3.5.1 High-Throughput Screening (HTS) for Drug Discovery Market: Region Footprint
  • 3.5.2 High-Throughput Screening (HTS) for Drug Discovery Market: Company Product Type Footprint
  • 3.5.3 High-Throughput Screening (HTS) for Drug Discovery Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global High-Throughput Screening (HTS) for Drug Discovery Market Size by Region
  • 4.1.1 Global High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Region (2021-2032)
  • 4.1.2 Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Region (2021-2032)
  • 4.1.3 Global High-Throughput Screening (HTS) for Drug Discovery Average Price by Region (2021-2032)
• 4.2 North America High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021-2032)
• 4.3 Europe High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021-2032)
• 4.4 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021-2032)
• 4.5 South America High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021-2032)
• 4.6 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 5.2 Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Type (2021-2032)
• 5.3 Global High-Throughput Screening (HTS) for Drug Discovery Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 6.2 Global High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Application (2021-2032)
• 6.3 Global High-Throughput Screening (HTS) for Drug Discovery Average Price by Application (2021-2032)

7 North America

• 7.1 North America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 7.2 North America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 7.3 North America High-Throughput Screening (HTS) for Drug Discovery Market Size by Country
  • 7.3.1 North America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Country (2021-2032)
  • 7.3.2 North America High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 8.2 Europe High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 8.3 Europe High-Throughput Screening (HTS) for Drug Discovery Market Size by Country
  • 8.3.1 Europe High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Market Size by Region
  • 9.3.1 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 10.2 South America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 10.3 South America High-Throughput Screening (HTS) for Drug Discovery Market Size by Country
  • 10.3.1 South America High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Country (2021-2032)
  • 10.3.2 South America High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Market Size by Country
  • 11.3.1 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa High-Throughput Screening (HTS) for Drug Discovery Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 High-Throughput Screening (HTS) for Drug Discovery Market Drivers
• 12.2 High-Throughput Screening (HTS) for Drug Discovery Market Restraints
• 12.3 High-Throughput Screening (HTS) for Drug Discovery Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of High-Throughput Screening (HTS) for Drug Discovery and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of High-Throughput Screening (HTS) for Drug Discovery
• 13.3 High-Throughput Screening (HTS) for Drug Discovery Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 High-Throughput Screening (HTS) for Drug Discovery Typical Distributors
• 14.3 High-Throughput Screening (HTS) for Drug Discovery Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source